Phase 3 Term birth Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 2Phase 3
Xylitol and the Prevention of Periodontal Disease and Preterm Birth Trial
developmental delayGingivitisPeriodontitis+2 more
University of Washington6,000 enrolled1 locationNCT07424846
Recruiting
Phase 3
Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries
Preterm BirthStillbirthSmall for Gestational Age (SGA)+1 more
NICHD Global Network for Women's and Children's Health1,134 enrolled7 locationsNCT06723392
Active
Phase 3Phase 4
Positive End-Expiratory Pressure (PEEP) Levels during Resuscitation of Preterm Infants at Birth (The POLAR Trial).
Preterm Birth
Murdoch Children's Research Institute906 enrolled11 locationsACTRN12618001686291
Active
Phase 3
Preventing Lung Disease Using Surfactant + Steroid (The PLUSS Trial)
Extremely preterm birthRespiratory distress syndrome
The Melbourne Children's Trial Centre1,060 enrolled18 locationsACTRN12617000322336
Completed
Phase 3
Australasian Antenatal Study To Evaluate the Role Of Intramuscular Dexamethasone versus Betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial
Long-term childhood neurosensory disability following antenatal corticosteroids given to women at risk of preterm birth at less than 34 weeks gestatation
Women’s and Children’s Hospital, SA1,499 enrolled1 locationACTRN12608000631303
Completed
Phase 3
Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial
Women at risk of preterm birth, at less than 32 weeks gestation, who have already received a course of prenatal corticosteroids.
Professor Caroline Crowther980 enrolled1 locationACTRN12606000318583